Type 2 Diabetes. Non-insulin-dependent diabetes mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: individuals between 30 and 60 years of their diabetes diagnosed diabetes center and at least 3 years of getting passed; lack of disorders and diseases of the liver and biliary and renal disorders; no professional athletes; not taking antioxidant supplements, selenium, zinc, beta carotene, omega-3 and at least 3 months before the study began; no alcohol; the willingness of patients to participate in the study; refusing to participate in other research projects; no change in dose or type of medication; do not use insulin. Exclusion criteria: those who consume less than 80 percent were crushed packages; people who have changed the type and dose of your medication; the patient's unwillingness to continue the study; start taking any antioxidant supplement; recent receiving insulin; to become pregnant during the study; diseases of liver and biliary and renal dysfunction during the study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting blood sugar. Timepoint: Before the intervention and after the intervention (3 months later). Method of measurement: Glucose oxidase method.;Glycosylated hemoglobin. Timepoint: Before the intervention and after the intervention (3 months later). Method of measurement: Spectrophotometric.;Insulin. Timepoint: Before the intervention and after the intervention (3 months later). Method of measurement: IRMA.;Insulin Resistance. Timepoint: Before the intervention and after the intervention (3 months later). Method of measurement: (glucose × insulin)/22.5.;Blood sugar levels two hours after a meal. Timepoint: Before the intervention and after the intervention (3 months later). Method of measurement: Glucose oxidase method.;Beta-cell function. Timepoint: Before the intervention and after the intervention (3 months later). Method of measurement: The amount of beta-cell function=(Fasting insulin × 20) / (fasting glucose, -3.5). | — |
Secondary
| Measure | Time frame |
|---|---|
| Added at 2016-11-29: HS-CRP. Timepoint: Added at 2016-11-29: At the beginning and the end of study period. Method of measurement: Added at 2016-11-29: 10 ml blood sample. | — |
Countries
Iran (Islamic Republic of)
Contacts
Yazd University of Medical Sciences